Which has the lower trailing P/E, BMY or MRK?

BMY has the lower trailing P/E: BMY trades at 17.57 and MRK at 37.14. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BMY or MRK?

Over the past five years, MRK grew revenue faster — BMY at a 2.52% CAGR versus MRK at 8.60%.

Does BMY or MRK pay a bigger dividend?

BMY yields 4.00% and MRK yields 2.55% based on trailing dividends and the latest price.

Is BMY or MRK more profitable?

BMY runs the higher net margin — BMY at 15.01% versus MRK at 13.62%.

How have BMY and MRK total returns compared?

Over the past 10 years, BMY delivered 2.02% and MRK delivered 12.39% annualized total return. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs Merck & Co., Inc. (MRK)

A side-by-side comparison of Bristol-Myers Squibb Company and Merck & Co., Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

BMY

Bristol-Myers Squibb Company

$129.88B

$63.60HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

MRK

Merck & Co., Inc.

$325.61B

$131.84HealthcareAt close: Jul 28, 2026, 4:00 PM ET

Total return — BMY vs MRK

growth of $100 · dividends reinvested · last 30y

BMY +790.3%MRK +999.2%MRK compounded faster

BMY MRK

BMY vs MRK: by the numbers

•MRK is the larger company ($325.61B vs $129.88B market cap).
•BMY trades at the lower trailing earnings multiple (17.57 vs 37.14 P/E), one valuation lens rather than an overall verdict.
•BMY converts more revenue to profit (15.01% vs 13.62% net margin).
•MRK grew revenue faster over the past five years (8.60% vs 2.52% CAGR).
•BMY pays the higher dividend yield (4.00% vs 2.55%).

Metrics side by side

Valuation

Metric	BMY	MRK
P/E ratio	17.57	37.14
Forward P/E	9.86	47.54
P/S ratio	2.64	4.97
P/B ratio	6.37	7.10
PEG ratio	1.87	1.81
EV / EBITDA	10.34	15.27
FCF yield	9.31%	4.33%

Profitability

Metric	BMY	MRK
Gross margin	68.75%	75.91%
Operating margin	25.67%	36.17%
Net margin	15.01%	13.62%
ROE	36.25%	19.48%
ROIC	13.90%	18.27%

Dividends

Metric	BMY	MRK
Dividend yield	4.00%	2.55%
Payout ratio	72.25%	46.03%

Growth (annualized)

Metric	BMY	MRK
Revenue CAGR (5Y)	2.52%	8.60%
EPS CAGR (5Y)	9.38%	21.21%
FCF CAGR (5Y)	-2.50%	15.69%
Total return CAGR (5Y)	2.73%	14.49%

Frequently asked

Which has the lower trailing P/E, BMY or MRK?: BMY has the lower trailing P/E: BMY trades at 17.57 and MRK at 37.14. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BMY or MRK?: Over the past five years, MRK grew revenue faster — BMY at a 2.52% CAGR versus MRK at 8.60%.
Does BMY or MRK pay a bigger dividend?: BMY yields 4.00% and MRK yields 2.55% based on trailing dividends and the latest price.
Is BMY or MRK more profitable?: BMY runs the higher net margin — BMY at 15.01% versus MRK at 13.62%.
How have BMY and MRK total returns compared?: Over the past 10 years, BMY delivered 2.02% and MRK delivered 12.39% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full MRK analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio Merck & P/E ratio Bristol-Myers Squibb dividend yield Merck & dividend yield Bristol-Myers Squibb ROE Merck & ROE Bristol-Myers Squibb operating margin Merck & operating margin Bristol-Myers Squibb revenue growth Merck & revenue growth Bristol-Myers Squibb free cash flow Merck & free cash flow

Bristol-Myers Squibb & Merck & appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.